PTSD is not classified as a neurological disorder. It is officially categorized as a psychiatric condition, falling under “Trauma- and Stressor-Related Disorders” in the DSM-5-TR, the diagnostic manual used by mental health professionals. The World Health Organization places it in a similar category called “Specific Stress-related Disorders” in the ICD-11. That said, the question isn’t unreasonable. PTSD produces measurable changes in brain structure, brain function, and nervous system activity that overlap with what you’d expect from a neurological condition. The distinction between “psychiatric” and “neurological” is less clean than most people assume.
How PTSD Is Officially Classified
The American Psychiatric Association moved PTSD into its own dedicated category in 2013 when the DSM-5 was published. Previously grouped with anxiety disorders, PTSD now sits under Trauma- and Stressor-Related Disorders, a category that requires exposure to a traumatic or stressful event as a prerequisite for diagnosis. The DSM-5-TR, updated in March 2022, kept the PTSD criteria unchanged.
Internationally, the WHO’s ICD-11 also treats PTSD as a stress-related disorder and added a sibling diagnosis, complex PTSD, for people exposed to prolonged or repeated trauma. Complex PTSD includes the core PTSD symptoms (re-experiencing the event, avoidance, and a persistent sense of threat) plus difficulties with emotional regulation, relationships, and self-concept. Neither classification system treats PTSD as neurological.
Why the Line Between Psychiatric and Neurological Is Blurry
The traditional rule of thumb is straightforward: if a condition is caused by recognizable physical damage to the central nervous system, it’s neurological. If the primary symptoms show up in thoughts, perceptions, moods, and behavior, it’s psychiatric. But as researchers at the Royal College of Psychiatrists have pointed out, this distinction quickly breaks down. What counts as “recognizable pathology”? Does a measurable reduction in brain volume qualify? What about changes that are quantitative rather than structural, where the brain looks normal but functions abnormally?
PTSD sits right in this gray zone. It doesn’t involve a tumor, a lesion, or the kind of structural damage you’d see in Parkinson’s or multiple sclerosis. But brain imaging consistently reveals physical changes that are hard to dismiss as purely psychological.
What PTSD Does to the Brain
Brain scans of people with PTSD show a consistent pattern of changes across three key regions. The hippocampus, which handles memory processing and helps distinguish past experiences from present ones, tends to be smaller. The amygdala, the brain’s threat-detection center, becomes overactive. And the medial prefrontal cortex, which normally helps regulate emotional responses and put the brakes on fear, shows reduced activity.
When researchers expose PTSD patients to reminders of their trauma (sounds, images, or scripted scenarios) while scanning their brains, the pattern sharpens. Blood flow drops in the prefrontal cortex, and the amygdala lights up. Areas involved in visual processing and spatial awareness also show decreased function. This isn’t an abstract chemical imbalance. It’s a visible disruption in how different brain regions communicate with each other.
MRI studies have confirmed that the hippocampus physically shrinks in people with PTSD, similar to what’s seen in major depression and other stress-related conditions. Research from the NIH has shown that in animal models, chronic stress also shrinks the dendrites of neurons in this region, the long branches brain cells use to receive signals from one another. Critically, though, this damage appears reversible. When PTSD and depression are successfully treated, the hippocampus gets measurably larger again, driven in part by the brain’s ability to generate new neurons.
A Nervous System Stuck in Threat Mode
Beyond brain structure, PTSD fundamentally disrupts the body’s stress-response systems. The clearest evidence involves norepinephrine (also called noradrenaline), the chemical messenger that drives the fight-or-flight response. In healthy people, this system activates during danger and settles down afterward. In PTSD, it stays elevated.
Research in experimental neurology describes this as increased “noradrenergic tone” throughout the central nervous system, essentially a persistent state of heightened alert. This elevated signaling doesn’t just cause the hypervigilance and exaggerated startle response that characterize PTSD. It also creates a feedback loop with other stress systems, particularly the interaction between the amygdala and the prefrontal cortex. The prefrontal cortex, already underperforming, becomes even less effective at calming the amygdala’s alarm signals.
The body’s slower stress-response system, which releases cortisol, is also disrupted. PTSD is associated with increased negative feedback in this hormonal axis, meaning the system overcompensates when trying to regulate cortisol levels. This dysregulation may help explain why people with chronic PTSD face higher rates of cardiovascular disease, autoimmune conditions, and metabolic problems.
Treatments That Target the Nervous System
Some of the most interesting evidence for PTSD’s neurological dimension comes from treatments that bypass talk therapy entirely and act directly on the nervous system. One example is the stellate ganglion block, a procedure that involves injecting a local anesthetic near a cluster of nerves in the neck that help regulate the fight-or-flight response. A randomized clinical trial published in JAMA Psychiatry tested this in active-duty service members with PTSD. Two injections spaced two weeks apart reduced symptom severity scores by an average of 12.6 points over eight weeks, compared to 6.1 points for the sham treatment group.
This doesn’t mean PTSD is “just” a nerve problem that can be fixed with an injection. Psychotherapy remains a primary treatment, and the psychological dimensions of PTSD, the meaning a person assigns to trauma, their social support, their coping patterns, are real and significant. But the fact that a nerve block can measurably reduce PTSD symptoms underscores how deeply the condition is wired into the body’s physical infrastructure.
So What Is PTSD, Really?
PTSD is a psychiatric disorder that produces neurological changes. It starts with a psychological event (trauma) and manifests through psychological symptoms (flashbacks, avoidance, emotional numbing, hyperarousal). But the mechanism connecting the trauma to those symptoms runs through measurable, physical changes in brain structure, brain chemistry, and nervous system function. Calling it purely psychiatric undersells the biology. Calling it neurological ignores the role of psychological experience and context.
The medical community hasn’t reclassified PTSD, and the neurobiological mechanisms that make some people vulnerable to developing it after trauma while others recover remain unclear. Ongoing research is working to identify molecular biomarkers that could predict who is at risk, integrating hormone profiles, gene expression, and other biological data. For now, PTSD occupies a space that challenges the neat separation between brain disorders and mind disorders, which may say more about the limits of that separation than about PTSD itself.